Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Patients with left ventricular systolic dysfunction are at risk of ventricular arrhythmias and sudden cardiac death. Meta-analyses of randomized controlled trials (RCTs) have demonstrated that, in ...

ORLANDO, FL—A wearable cardioverter-defibrillator (WCD) commercially available in the United States since 2001 has disappointed in its first randomized study, although experts would not rule out ...

To the Editor: Hohnloser et al. (Dec. 9 issue), 1 who conducted the Defibrillator in Acute Myocardial Infarction Trial (DINAMIT), assume that implantable cardioverter–defibrillator (ICD) therapy early ...

KIRKLAND, Wash.--(BUSINESS WIRE)--Kestra ™ Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE ® Wearable ...

Diagnosing contact sensitivity to an ICD can be challenging because many patients are first suspected of having an infection, due to cutaneous involvement primarily at or near the site of implantation ...

DALLAS, March 2, 2010 — A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the ...

This is a preview. Log in through your library . Abstract Objectives: In high-risk cardiac patients the treatment of life-threatening arrhythmias with an implantable ...

St. Louis Blues defenseman Jay Bouwmeester, who needed a defibrillator to be revived after suffering a cardiac episode on the team bench during a game, has undergone a successful Implantable ...

Element Science acquired a CE mark in Europe and a green light in the U.K. for its patch-based cardioverter defibrillator, designed to provide an easier-to-wear device for people in danger of sudden ...